Correspondence 0001493152-24-020668 from Imunon, Inc. (IMNN)

Imunon, Inc.
Date: May 20, 2024 · CIK: 0000749647 · Accession: 0001493152-24-020668

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-279425

Date

May 22, 2024

Author

Imunon

Form

CORRESP

Company

Imunon, Inc.

Letter

Re: Imunon, Inc. (the “Company”)

May 20, 2024

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Attn: Jimmy McNamara

Registration Statement Filed on Form S-3 (the “Registration Statement”)

File No. 333-279425

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effective date for the above-referenced Registration Statement be accelerated to 5:00 p.m., Eastern Time, on May 22, 2024, or as soon as practicable thereafter.

Please contact Megan Gates of Covington & Burling LLP at (617) 603-8805 or mgates@cov.com with any questions you may have regarding this request. In addition, please notify Ms. Gates by telephone when this request for acceleration has been granted.

Respectfully,
Imunon,
Inc.

Show Raw Text

CORRESP
1
filename1.htm

May
20, 2024

Via
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

Attn:
Jimmy McNamara

  Re:
  Imunon,
  Inc. (the “Company”)

  Registration
  Statement Filed on Form S-3 (the “Registration Statement”)

  File
  No. 333-279425

Ladies
and Gentlemen:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effective date for the above-referenced
Registration Statement be accelerated to 5:00 p.m., Eastern Time, on May 22, 2024, or as soon as practicable thereafter.

Please
contact Megan Gates of Covington & Burling LLP at (617) 603-8805 or mgates@cov.com with any questions you may have regarding this
request. In addition, please notify Ms. Gates by telephone when this request for acceleration has been granted.

    Respectfully,

    Imunon,
    Inc.

    By:
    /s/
    Jeffrey W. Church

    Name:
    Jeffrey
    W. Church

    Title:
    Chief
    Financial Officer

  cc:
  Megan
  Gates, Covington & Burling LLP

SecProbe.io